Examinant per Autoria "Arance, Ana"
Mostrant 1 - 4 de 4
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert Genomic deletions explain the generation of alternative BRAF isoforms conferring resistance to MAPK inhibitors in melanoma(Elsevier, 2024) Aya, Francisco; Lanuza Gracia, Pablo; González-Pérez, Abel; Bonnal, Sophie; Mancini, Estefanía; López Bigas, Núria; Arance, Ana; Valcárcel, J. (Juan)
Ítem Accés Obert Safe anti-programmed cell death-1 rechallenge with antibody switching after immune-related adverse events: brief communication(Future Science Group, 2021) Aya, Francisco; González Navarro, E. Azucena; Martínez, Clara M.; Carcelero, Esther; Arance, Ana
Ítem Accés Obert SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019)(SpringerOpen, 2020) Majem, Margarita; García-Martínez, E.; Martínez-García, Maria; Muñoz Couselo, Eva; Rodríguez-Abreu, D.; Alvarez, R.; Arance, Ana; Berrocal, A.; de la Cruz-Merino, L.; López-Martín, J.A.
Ítem Només Metadades Targeting BRAF mutant pre-mRNA alternative splicing in melanoma(Universitat Pompeu Fabra, 2023-02-24T13:58:39Z) Aya Moreno, Francisco; Valcárcel, J. (Juan); Arance, Ana; Universitat Pompeu Fabra. Departament de Medicina i Ciències de la Vida